| Title: | Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking |
| Journal: | Leukemia |
| Published: | 10 Jun 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32518416/ |
| DOI: | https://doi.org/10.1038/s41375-020-0896-8 |
| URL: | https://eprints.soton.ac.uk/440991/1/34426_2_merged_1589890551.pdf |
| Citations: | 110 (53 in last 2 years) as of 8 Aug 2024 |
Publication 3686
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We sought to determine the significance of myeloid clonal hematopoiesis (CH) in the UK Biobank cohort (n = 502,524, median age = 58 years). Utilizing SNP array (n = 486,941) and whole exome sequencing data (n = 49,956), we identified 1166 participants with myeloid CH, defined by myeloid-associated mosaic chromosome abnormalities (mCA) and/or likely somatic driver mutations in DNMT3A, TET2, ASXL1, JAK2, SRSF2, or PPM1D. Myeloid CH increased by 1.1-fold per annum (myeloid mCA, P = 1.57 × 10−38; driver mutations, P = 5.89 × 10−47). Genome-wide association analysis identified two distinct signals within TERT that predisposed to myeloid CH, plus a weaker signal corresponding to the JAK2 46/1 haplotype. Specific subtypes of myeloid CH were associated with several blood features and clinical phenotypes, including TET2 mutations and chronic obstructive pulmonary disease. Smoking history was significantly associated with myeloid CH: 53% of myeloid CH cases were smokers compared to 44% of controls (P = 3.38 × 10−6), a difference principally due to current (OR = 1.10; P = 6.14 × 10−6) rather than past smoking (P = 0.08). Breakdown of CH by specific mutation type revealed that ASXL1 loss of function mutations were most strongly associated with current smoking status (OR = 1.07; P = 1.92 × 10−5), and the only abnormality associated with past smoking (OR = 1.04; P = 0.0026). We suggest that the inflammatory environment induced by smoking may promote the outgrowth of ASXL1-mutant clones.</p>
3 Authors
- Ahmed A. Z. Dawoud
- William J. Tapper
- Nicholas C. P. Cross
1 Application
| Application ID | Title |
|---|---|
| 35273 | Myeloproliferative neoplasms and clonal haematopoiesis |
Enabling scientific discoveries that improve human health